Related Experiment Video
Updated: Feb 1, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Alirocumab for low-density lipoprotein cholesterol lowering
1President, Sterling Research Group & Clinical Professor, Division of Cardiovascular Health & Disease, University of Cincinnati, Cincinnati, OH 45219-513, USA.
New PCSK9 inhibitors, like alirocumab, effectively lower LDL cholesterol when combined with statins. The ODYSSEY OUTCOMES trial demonstrates their efficacy and safety in reducing cardiovascular events.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Pharmacology
Background:
- Ischemic heart disease and stroke are leading global causes of mortality.
- Atherosclerosis, driven by low-density lipoprotein cholesterol (LDL-C) deposition, underlies these conditions.
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates LDL-C by promoting LDL receptor degradation.
Purpose of the Study:
- To review the efficacy and safety of alirocumab, a PCSK9 inhibitor.
- To analyze the impact of alirocumab, particularly in the context of the ODYSSEY OUTCOMES trial.
Main Methods:
- Review of scientific literature and clinical trial data.
- Focus on alirocumab as a monoclonal antibody targeting PCSK9.
- Inclusion of data from the ODYSSEY OUTCOMES trial.
Main Results:
- PCSK9 inhibitors, including alirocumab, achieve significant reductions in LDL-C levels.
- Combination therapy with statins enhances LDL-C lowering.
- The ODYSSEY OUTCOMES trial provides key data on alirocumab's clinical outcomes.
Conclusions:
- Alirocumab represents a significant advancement in managing hyperlipidemia.
- PCSK9 inhibition offers a potent strategy to reduce cardiovascular risk.
- Further research and clinical application of PCSK9 inhibitors are warranted.
Related Concept Videos
Vapor Pressure Lowering
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Density
Current Density
Strain-Energy Density
In the elastic region of a material, the relationship between the stress and the strain is linear and follows Hooke's Law. The strain energy density in this region...

